Search results for "NOE"

showing 10 items of 825 documents

Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation

2005

Neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) are involved in neuropeptide degradation and may modulate neurogenic inflammation. We therefore explored the effect of specific blockers of NEP and ACE on the intensity of neurogenic inflammation. We investigated eight subjects on three occasions. Two pairs of microdialysis fibers equipped with intraluminal wires were inserted intracutaneously into the volar forearms and electrical stimuli were delivered via the intraluminal electrodes. The microdialysis fibers were perfused either with normal saline, phosphoramidon (NEP inhibitor), or captopril (ACE inhibitor). CGRP release was assessed in the microdialysis eluate via a sp…

AdultMalemedicine.medical_specialtyMicrodialysisCaptoprilTime FactorsCalcitonin Gene-Related PeptideMicrodialysisPeptidyl-Dipeptidase AImmunoenzyme Techniqueschemistry.chemical_compoundDevelopmental NeuroscienceInternal medicineLaser-Doppler FlowmetrymedicineHumansDrug InteractionsEnzyme InhibitorsSkinNerve Fibers UnmyelinatedNeurogenic inflammationbiologyPhosphoramidonGlycopeptidesCaptoprilAngiotensin-converting enzymeElectric StimulationVasodilationAllodyniaEndocrinologyNeurologychemistryHyperalgesiaACE inhibitorHyperalgesiabiology.proteinFemaleNeprilysinNeurogenic Inflammationmedicine.symptommedicine.drugExperimental Neurology
researchProduct

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome

2003

Background: High serum levels of soluble intercellular adhesion molecule-1(s-ICAM-1/s-CD54) have been associated with adverse clinical features and poor outcome in chronic lymphocytic leukemia, Hodgkin’s disease and non-Hodgkin’s lymphoma, but their value in the different subtypes of non-Hodgkin’s lymphoma has not been well addressed. Patients and methods: Our aim was to study the serum levels of s-ICAM-1 in diffuse large B-cell lymphoma (DLBCL) and to correlate them with clinical characteristics and outcome. We analyzed the serum levels of s-ICAM-1 in a series of 55 patients with DLBCL diagnosed in a single institution. s-ICAM-1 levels were quantified by an immunoenzymatic assay. Median ag…

AdultMalemedicine.medical_specialtyPathologyLymphoma B-CellChronic lymphocytic leukemiaGastroenterologyImmunoenzyme TechniquesInternational Prognostic IndexRisk Factorshemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansSurvival analysisAgedAged 80 and overL-Lactate DehydrogenaseBeta-2 microglobulinbusiness.industryLymphoma Non-HodgkinLarge-cell lymphomaHematologyMiddle AgedIntercellular Adhesion Molecule-1Prognosismedicine.diseaseSurvival AnalysisLymphomaTreatment OutcomeOncologyB symptomsCase-Control StudiesLymphatic MetastasisDisease ProgressionFemaleLymphoma Large B-Cell Diffusemedicine.symptombusinessDiffuse large B-cell lymphomaAnnals of Oncology
researchProduct

A Novel Loss-of-Function Mutation (N48K) in the PTEN Gene in a Spanish Patient with Cowden Disease

2003

Cowden disease, also known as multiple hamartoma syndrome, is a rare disease inherited in an autosomal dominant pattern, which confers a high risk of developing breast and thyroid carcinomas. Mutations in PTEN, a tumor suppressor gene located on chromosome 10q23, have been identified in patients with Cowden disease. In this work, the direct sequencing of all coding regions of the PTEN gene led us to the identification of N48K, a new germline PTEN missense mutation, in a patient suffering from Cowden disease. The genetic analysis of 200 chromosomes from healthy individuals revealed that the variant was not common in our population. Moreover, by functional analysis we found that the ability o…

AdultPTENcongenital hereditary and neonatal diseases and abnormalitiesTumor suppressor geneDNA Mutational AnalysisMolecular Sequence DataLoss of Heterozygositygenetic analysisDermatologyProtein Serine-Threonine Kinasesmedicine.disease_causeProto-Oncogene MasBiochemistryGenètica molecularfunctional analysisLoss of heterozygosityStructure-Activity RelationshipProto-Oncogene ProteinsmedicineLeukocytesMissense mutationPTENHumansPoint MutationCowden diseaseAmino Acid SequenceMolecular BiologyTumorsGeneticsMutationbiologySequence Homology Amino AcidPoint mutationTumor Suppressor ProteinsPTEN PhosphohydrolaseMultiple hamartoma syndromeCowden syndromeCell Biologymedicine.diseasePhosphoric Monoester HydrolasesN48KSpainbiology.proteinCancer researchFemaleHamartoma Syndrome MultipleProto-Oncogene Proteins c-akt
researchProduct

Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas

1991

The expression patterns of intermediate filament proteins of primary and metastatic endometrial (n = 18) and ovarian (n = 24) adenocarcinomas were analyzed by immunocytochemistry using a panel of specific antibodies and by gel electrophoresis of cytoskeletal preparations, followed by immunoblotting. All cells of all endometrial adenocarcinomas studied contained the "simple epithelial"-type cytokeratins (CKs) 8, 18, and (mostly) 19, with variable numbers of cells also positive for CK 7 and vimentin. In addition, most of these tumors contained individual cells or groups of cells that were positive for the stratification-related CKs 4, 5, 6, 13, 14, and 17. The latter CKs were often associated…

AdultPathologymedicine.medical_specialtyCellular differentiationImmunocytochemistryVimentinAdenocarcinomaPathology and Forensic MedicineImmunoenzyme TechniquesIntermediate Filament ProteinsOvarian carcinomaGlial Fibrillary Acidic ProteinmedicineHumansIntermediate filamentAgedOvarian NeoplasmsbiologyCarcinomaMiddle Agedmedicine.diseaseEndometrial NeoplasmsSerous fluidMicroscopy Fluorescencebiology.proteinAdenocarcinomaElectrophoresis Polyacrylamide GelFemaleClear cellHuman Pathology
researchProduct

Imunohistochemical Demonstration of Carcinoembryonic Antigen (CEA) in 120 Mammary Carcinomas and its Correlation with Tumor Type, Grading, Staging Pl…

1985

Antisera to CEA were used for the immunohistochemical localization and quantification of this antigen in 120 Bouin-fixed, paraffin embedded mammary carcinomas. These results were compared to tumor type, grading, staging, biochemical receptor status, cytosolic CEA-levels of the same tumors, and preoperative plasma CEA-levels. Mammary carcinomas were usually characterized by a low percentage of CEA-positive tumor cells: 50.9% of the cases contained more than 5% CEA-positive tumor cells and were therefore defined as being CEA-histopositive in this study. A relation could be shown between CEA-histopositivity and the histologic tumor type. The majority of invasive lobular carcinomas, tubular, an…

AdultPathologymedicine.medical_specialtyReceptor Statusendocrine system diseasesBreast NeoplasmsPathology and Forensic MedicineImmunoenzyme TechniquesCarcinoembryonic antigenAntigenAntigens NeoplasmmedicineCarcinomaHumansneoplasmsEstrogen Receptor StatusGrading (tumors)Agedbiologybusiness.industryCarcinomaCell BiologyMiddle Agedmedicine.diseasedigestive system diseasesCarcinoembryonic AntigenCarcinoma Intraductal NoninfiltratingReceptors EstrogenInvasive lobular carcinomabiology.proteinImmunohistochemistryFemalebusinessPathology - Research and Practice
researchProduct

Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix. Demonstration of diverse cytokeratin polypeptides in reser…

1987

We have analyzed the expression of cytokeratin polypeptides in subcolumnar reserve cells of the human uterine endocervical mucosa and the other epithelial cells using immunoperoxidase and immunofluorescence microscopy as well as by applying two-dimensional gel electrophoresis to microdissected cytoskeletal preparations. Endocervical columnar cells were uniformly positive for antibodies directed against the simple epithelium-type cytokeratins nos. 7, 8, 18, and 19, while a variable proportion of these cells was stained by an antibody against cytokeratin no. 4. Reserve cells were not only positive for cytokeratins nos. 8 (weakly and variably) and 19 but were also decorated by antibody KA 1, w…

AdultPathologymedicine.medical_specialtySquamous DifferentiationImmunocytochemistryCervix UteriBiologyEpitheliumImmunoenzyme TechniquesCytokeratinKeratinmedicineHumansEndocervical MucosaAgedchemistry.chemical_classificationImmunoperoxidaseAntibodies MonoclonalEpithelial CellsMiddle Agedmedicine.diseaseEpitheliumSquamous metaplasiamedicine.anatomical_structurechemistryKeratinsElectrophoresis Polyacrylamide GelFemaleVirchows Archiv. B, Cell pathology including molecular pathology
researchProduct

Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue.

1994

Epithelial distribution of filaggrin, a histidine-rich protein related to squamous terminal differentiation, was investigated in 87 cervical biopsies using an avidin-biotin-peroxidase technique with a monoclonal anti-human filaggrin antibody (AKH1). Normal squamous cervical epithelium exhibited a positive homogeneous immunoperoxidase stain in the upper parabasal, intermediate and superficial cell layers. Similar findings were obtained in cervical condylomas, although full-thickness staining was observed in 35.7% of the cases (P < 0.001). Filaggrin expression in CIN was inversely related to the severity of the lesion (P < 0.001). An irregular staining pattern was present in most high-grade C…

AdultPathologymedicine.medical_specialtySquamous DifferentiationUterine Cervical NeoplasmsCervix UteriFilaggrin ProteinsLesionImmunoenzyme TechniquesUterine Cervical DiseasesIntermediate Filament ProteinsPredictive Value of TestsmedicineBiomarkers TumorHumansskin and connective tissue diseasesCervixintegumentary systemImmunoperoxidasebusiness.industryObstetrics and GynecologyGeneral MedicineUterine Cervical DysplasiaEpitheliumStainingmedicine.anatomical_structureCondylomata AcuminataCarcinoma Squamous CellImmunohistochemistryFemalemedicine.symptomEpidermisbusinessPrecancerous ConditionsCarcinoma in SituFilaggrin
researchProduct

Abnormal Immunoexpression of Cell Adhesion Molecules (CAMs) in Cervical Cancer

2010

Artículo publicado en: International Journal of Surgical Pathology published online 18 July 2010 The purpose of this study was to examine the immunoexpression of cell adhesion molecules (CAMs) E-cadherin, CD44s, and CD44v3 in cervical cancer and compare it with that in benign exo-endocervical tissue. In all, 81 cervical cancer biopsy specimens and 22 benign controls were included. Primary monoclonal antibodies NHC-38, F10-44-2, and 3G5 for E-cadherin, CD44s, and CD44v3 were used, respectively. Statistical significance was evaluated by the ?2 test. Antigen expression was significantly different in cervical cancer specimens compared with controls, showing marked decrease in membrane expressio…

AdultPathologymedicine.medical_specialtyUterine Cervical NeoplasmsAdenocarcinomaAlphapapillomavirusBiologyPathology and Forensic MedicineImmunoenzyme TechniquesBiopsyBiomarkers TumormedicineHumansDNA Probes HPVCell adhesionAgedCervical cancermedicine.diagnostic_testCadherinCell adhesion moleculeCD44v3Papillomavirus InfectionsE-cadherinCancerArtículosMiddle AgedFacultad de Farmacia y BioanálisisCadherinsmedicine.diseaseImmunohistochemistryHyaluronan ReceptorsTissue Array AnalysisDNA ViralCervical cancerCD44sImmunohistochemistryFemaleSurgeryAnatomyImmunostainingInternational Journal of Surgical Pathology
researchProduct

Obstructive sleep apnoea in adult patients post-tonsillectomy

2021

Background: The impact of removing the upper airway lymphoid tissue and in particular, tonsillectomy, in adults with OSA has not been demonstrated in large populations. Aims: To compare the severity of OSA and the prevalence of cardiovascular, metabolic and respiratory co-morbidities between patients with OSA who had undergone previous tonsillectomy and those who had not. Methods: The 19,711 participants in this study came from the European sleep apnea database (ESADA) which comprises data from unselected adult patients aged 18–80 years with a history of symptoms suggestive of OSA referred to sleep centers throughout Europe. Results: There were no differences between the two groups in terms…

AdultPediatricsmedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]ESADALymphoid tissue overgrowthSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesSleep apnoea0302 clinical medicinemedicineHumansMass indexRespiratory systemTonsillectomySleep Apnea ObstructiveAdult patientsbusiness.industrySleep apneaGeneral MedicineESADA ; Lymphoid tissue overgrowth ; Sleep apnoea ; Tonsillectomy.medicine.diseaseSleep in non-human animalsrespiratory tract diseasesTonsillectomy[SDV] Life Sciences [q-bio]Europe030228 respiratory systemDiabetes Mellitus Type 2Lower prevalenceTonsillectomy.AirwaybusinessSleep030217 neurology & neurosurgery
researchProduct

Management of pharyngeal collapse in patients affected by moderate obstructive sleep apnoea syndrome

2022

This study reports our experience in a selected cohort of patients affected by mild-moderate OSAS, without tonsillar obstruction, and treated with pharyngoplasty.In a case-control retrospective study, we compared modified expansion sphincter pharyngoplasty (MESP) to modified barbed reposition pharyngoplasty (MBRP) in adult patients with oropharyngeal transversal collapse with a BMI ≤ 30 kg/mWe enrolled 20 patients: 10 treated with MESP and 10 treated with MBRP. Mean apnoea-hypoapnoea index (AHI) was 22.8 (± 5.63). We observed in both groups a significant reduction of AHI and oropharyngeal obstruction (p = 0.01), with a success rate, according with Sher's criteria, of 90% for MESP and 80% fo…

AdultSleep Apnea Obstructivesoft palatePolysomnographySnoringPlastic Surgery ProceduresCohort StudiesTreatment OutcomeGeneral EnergyOtorhinolaryngologyCase-Control StudiesHumansPharynxsleep-disorderedbreathingobstructive sleep apnoea hypopnoea syndromeRetrospective StudiesActa Otorhinolaryngologica Italica
researchProduct